Rohit Budhiraja, M.B.,B.S.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sleep Apnea, Obstructive | 23 | 2021 | 1899 | 3.180 |
Why?
|
| Continuous Positive Airway Pressure | 16 | 2021 | 580 | 2.600 |
Why?
|
| Sleep Apnea Syndromes | 10 | 2020 | 984 | 1.170 |
Why?
|
| Polysomnography | 14 | 2023 | 1871 | 0.750 |
Why?
|
| Hypertension | 9 | 2021 | 8616 | 0.740 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 5 | 2015 | 1106 | 0.690 |
Why?
|
| Nocturnal Myoclonus Syndrome | 1 | 2019 | 52 | 0.660 |
Why?
|
| Oxygen | 6 | 2021 | 4270 | 0.570 |
Why?
|
| Sleep | 8 | 2023 | 4818 | 0.550 |
Why?
|
| Documentation | 1 | 2023 | 917 | 0.540 |
Why?
|
| Patient Compliance | 6 | 2021 | 2697 | 0.520 |
Why?
|
| Restless Legs Syndrome | 3 | 2015 | 235 | 0.510 |
Why?
|
| Disorders of Excessive Somnolence | 3 | 2017 | 279 | 0.480 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 4 | 2015 | 3252 | 0.470 |
Why?
|
| Cardiovascular Diseases | 9 | 2019 | 15662 | 0.400 |
Why?
|
| Wakefulness | 1 | 2017 | 1284 | 0.350 |
Why?
|
| Arousal | 3 | 2021 | 1180 | 0.350 |
Why?
|
| Heartburn | 1 | 2010 | 71 | 0.330 |
Why?
|
| Nasal Cavity | 2 | 2016 | 310 | 0.330 |
Why?
|
| Hypertension, Pulmonary | 3 | 2005 | 1605 | 0.320 |
Why?
|
| Sleep-Wake Transition Disorders | 1 | 2007 | 2 | 0.290 |
Why?
|
| Endothelium, Vascular | 5 | 2007 | 4428 | 0.290 |
Why?
|
| Xanthine Oxidase | 2 | 2003 | 69 | 0.270 |
Why?
|
| REM Sleep Behavior Disorder | 1 | 2007 | 111 | 0.260 |
Why?
|
| Sleep Stages | 1 | 2010 | 706 | 0.250 |
Why?
|
| Glucose Metabolism Disorders | 1 | 2005 | 52 | 0.250 |
Why?
|
| Ambulatory Care | 1 | 2016 | 2783 | 0.240 |
Why?
|
| Vascular Diseases | 1 | 2013 | 1162 | 0.230 |
Why?
|
| Xanthine Dehydrogenase | 1 | 2003 | 18 | 0.230 |
Why?
|
| Health Education | 1 | 2010 | 1059 | 0.210 |
Why?
|
| Gastroesophageal Reflux | 1 | 2010 | 836 | 0.200 |
Why?
|
| Pressure | 1 | 2005 | 1172 | 0.200 |
Why?
|
| Severity of Illness Index | 5 | 2017 | 15949 | 0.180 |
Why?
|
| Hypertension, Portal | 1 | 2003 | 230 | 0.180 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2003 | 1169 | 0.170 |
Why?
|
| Humans | 45 | 2023 | 768171 | 0.160 |
Why?
|
| Estrogens | 2 | 2012 | 1536 | 0.150 |
Why?
|
| Comorbidity | 4 | 2019 | 10590 | 0.150 |
Why?
|
| Estradiol | 1 | 2003 | 1951 | 0.130 |
Why?
|
| Chronic Disease | 1 | 2011 | 9384 | 0.130 |
Why?
|
| Mental Disorders | 1 | 2016 | 6873 | 0.130 |
Why?
|
| Multicenter Studies as Topic | 1 | 2019 | 1737 | 0.120 |
Why?
|
| Prevalence | 4 | 2019 | 15869 | 0.120 |
Why?
|
| Electroencephalography | 1 | 2010 | 6314 | 0.110 |
Why?
|
| Incidence | 4 | 2021 | 21538 | 0.110 |
Why?
|
| Male | 23 | 2019 | 364731 | 0.110 |
Why?
|
| Weight Gain | 2 | 2014 | 2359 | 0.110 |
Why?
|
| Prospective Studies | 5 | 2019 | 54924 | 0.110 |
Why?
|
| Middle Aged | 15 | 2019 | 223487 | 0.100 |
Why?
|
| Respiration | 2 | 2012 | 1665 | 0.100 |
Why?
|
| Obesity | 3 | 2010 | 13091 | 0.100 |
Why?
|
| Female | 22 | 2019 | 397187 | 0.100 |
Why?
|
| Sleep Medicine Specialty | 1 | 2012 | 72 | 0.100 |
Why?
|
| Random Allocation | 1 | 2016 | 2395 | 0.090 |
Why?
|
| Cohort Studies | 4 | 2019 | 41753 | 0.090 |
Why?
|
| Michigan | 1 | 2011 | 330 | 0.090 |
Why?
|
| Coronary Disease | 1 | 2004 | 5919 | 0.080 |
Why?
|
| Fourier Analysis | 1 | 2010 | 439 | 0.080 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2012 | 418 | 0.080 |
Why?
|
| Adult | 12 | 2021 | 223646 | 0.070 |
Why?
|
| Spectrum Analysis | 1 | 2010 | 449 | 0.070 |
Why?
|
| Linear Models | 1 | 2017 | 5884 | 0.070 |
Why?
|
| Electrooculography | 1 | 2007 | 113 | 0.070 |
Why?
|
| Medical Staff | 1 | 2007 | 40 | 0.070 |
Why?
|
| Aged | 8 | 2019 | 171502 | 0.070 |
Why?
|
| Telemetry | 1 | 2007 | 200 | 0.060 |
Why?
|
| Logistic Models | 2 | 2017 | 13290 | 0.060 |
Why?
|
| Pulmonary Artery | 2 | 2003 | 1946 | 0.060 |
Why?
|
| Transducers | 1 | 2005 | 243 | 0.060 |
Why?
|
| Risk Reduction Behavior | 1 | 2010 | 1119 | 0.060 |
Why?
|
| Glucose Intolerance | 1 | 2008 | 579 | 0.060 |
Why?
|
| Estrogen Antagonists | 1 | 2003 | 151 | 0.050 |
Why?
|
| Young Adult | 3 | 2019 | 60066 | 0.050 |
Why?
|
| Drug Resistance | 1 | 2009 | 1599 | 0.050 |
Why?
|
| Precipitin Tests | 1 | 2003 | 816 | 0.050 |
Why?
|
| Cross-Sectional Studies | 4 | 2012 | 26379 | 0.050 |
Why?
|
| Accreditation | 1 | 2006 | 477 | 0.050 |
Why?
|
| Long-Term Care | 1 | 2007 | 631 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2019 | 10397 | 0.050 |
Why?
|
| Retrospective Studies | 6 | 2021 | 81760 | 0.050 |
Why?
|
| Aged, 80 and over | 5 | 2019 | 59626 | 0.050 |
Why?
|
| Time | 1 | 2004 | 552 | 0.050 |
Why?
|
| Electromyography | 1 | 2007 | 1401 | 0.050 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 2003 | 277 | 0.050 |
Why?
|
| Growth Substances | 1 | 2004 | 760 | 0.050 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2003 | 1730 | 0.050 |
Why?
|
| Specialization | 1 | 2006 | 779 | 0.050 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2003 | 393 | 0.050 |
Why?
|
| Vasoconstriction | 1 | 2004 | 592 | 0.050 |
Why?
|
| Thrombophilia | 1 | 2004 | 308 | 0.050 |
Why?
|
| Health Services | 1 | 2005 | 755 | 0.040 |
Why?
|
| Health Behavior | 1 | 2012 | 2650 | 0.040 |
Why?
|
| Hypercholesterolemia | 1 | 2007 | 1145 | 0.040 |
Why?
|
| Quality of Life | 3 | 2013 | 13490 | 0.040 |
Why?
|
| Catheterization | 1 | 2005 | 1430 | 0.040 |
Why?
|
| Vascular Resistance | 1 | 2003 | 939 | 0.040 |
Why?
|
| Vasodilation | 1 | 2004 | 967 | 0.040 |
Why?
|
| Time Factors | 3 | 2017 | 40220 | 0.040 |
Why?
|
| Antihypertensive Agents | 1 | 2009 | 2029 | 0.040 |
Why?
|
| Microcirculation | 1 | 2003 | 1281 | 0.040 |
Why?
|
| Renal Dialysis | 1 | 2008 | 1791 | 0.040 |
Why?
|
| Follow-Up Studies | 3 | 2016 | 39354 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2010 | 5315 | 0.040 |
Why?
|
| Research | 1 | 2007 | 1979 | 0.040 |
Why?
|
| Diagnostic Errors | 1 | 2005 | 1281 | 0.040 |
Why?
|
| Depression | 1 | 2017 | 8230 | 0.040 |
Why?
|
| Medicine | 1 | 2006 | 945 | 0.040 |
Why?
|
| Adolescent | 2 | 2019 | 89169 | 0.040 |
Why?
|
| Up-Regulation | 2 | 2003 | 4149 | 0.040 |
Why?
|
| Hypnotics and Sedatives | 1 | 2005 | 1191 | 0.040 |
Why?
|
| Heart Rate | 1 | 2008 | 4214 | 0.030 |
Why?
|
| Overweight | 1 | 2008 | 2448 | 0.030 |
Why?
|
| Syndrome | 1 | 2003 | 3273 | 0.030 |
Why?
|
| Risk Factors | 5 | 2012 | 74944 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2003 | 5028 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2007 | 3140 | 0.030 |
Why?
|
| Inflammation | 2 | 2007 | 10873 | 0.030 |
Why?
|
| Antioxidants | 1 | 2003 | 1676 | 0.030 |
Why?
|
| Kidney Failure, Chronic | 1 | 2008 | 2496 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2003 | 2152 | 0.030 |
Why?
|
| Societies | 1 | 2016 | 107 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2006 | 2785 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 2 | 2003 | 5797 | 0.030 |
Why?
|
| Diagnosis, Differential | 2 | 2007 | 13013 | 0.030 |
Why?
|
| Lung | 2 | 2004 | 10101 | 0.030 |
Why?
|
| Age Factors | 2 | 2012 | 18415 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2010 | 14729 | 0.030 |
Why?
|
| Electrocardiography | 1 | 2007 | 6412 | 0.030 |
Why?
|
| Intensive Care Units | 1 | 2007 | 3800 | 0.030 |
Why?
|
| Heart | 1 | 2005 | 4446 | 0.030 |
Why?
|
| Physician-Patient Relations | 1 | 2005 | 3269 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2003 | 19025 | 0.020 |
Why?
|
| Research Design | 1 | 2007 | 6209 | 0.020 |
Why?
|
| United States | 4 | 2016 | 73039 | 0.020 |
Why?
|
| Rats | 2 | 2003 | 23782 | 0.020 |
Why?
|
| Body Weight | 2 | 2013 | 4627 | 0.020 |
Why?
|
| Primary Health Care | 1 | 2005 | 4746 | 0.020 |
Why?
|
| Anthropometry | 1 | 2013 | 1346 | 0.020 |
Why?
|
| Body Mass Index | 2 | 2021 | 13053 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2016 | 65379 | 0.020 |
Why?
|
| Advisory Committees | 1 | 2012 | 796 | 0.020 |
Why?
|
| Cheyne-Stokes Respiration | 1 | 2007 | 38 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 2013 | 2107 | 0.020 |
Why?
|
| Pennsylvania | 1 | 2008 | 615 | 0.020 |
Why?
|
| Physician Impairment | 1 | 2007 | 71 | 0.020 |
Why?
|
| Prognosis | 2 | 2008 | 30009 | 0.020 |
Why?
|
| Glucose Tolerance Test | 1 | 2008 | 1183 | 0.010 |
Why?
|
| Oximetry | 1 | 2007 | 462 | 0.010 |
Why?
|
| Sleep, REM | 1 | 2007 | 595 | 0.010 |
Why?
|
| Animals | 3 | 2004 | 169285 | 0.010 |
Why?
|
| Work Schedule Tolerance | 1 | 2007 | 553 | 0.010 |
Why?
|
| Carbon Dioxide | 1 | 2007 | 1148 | 0.010 |
Why?
|
| Child | 2 | 2012 | 80917 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2004 | 18065 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 2008 | 1880 | 0.010 |
Why?
|
| Smoke | 1 | 2003 | 242 | 0.010 |
Why?
|
| Workload | 1 | 2007 | 849 | 0.010 |
Why?
|
| Reference Values | 1 | 2008 | 4939 | 0.010 |
Why?
|
| Cell Hypoxia | 1 | 2003 | 662 | 0.010 |
Why?
|
| Societies, Medical | 1 | 2012 | 3968 | 0.010 |
Why?
|
| Sleep Deprivation | 1 | 2007 | 848 | 0.010 |
Why?
|
| Accidents, Traffic | 1 | 2005 | 818 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2013 | 12466 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2003 | 3590 | 0.010 |
Why?
|
| Health Surveys | 1 | 2007 | 4057 | 0.010 |
Why?
|
| Mice | 1 | 2004 | 82049 | 0.010 |
Why?
|
| Weight Loss | 1 | 2008 | 2721 | 0.010 |
Why?
|
| Drug Prescriptions | 1 | 2005 | 1668 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2008 | 9669 | 0.010 |
Why?
|
| Patient Education as Topic | 1 | 2006 | 2337 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2013 | 24318 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2003 | 8316 | 0.010 |
Why?
|
| Disease Progression | 1 | 2008 | 13668 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2007 | 20225 | 0.000 |
Why?
|
| RNA, Messenger | 1 | 2003 | 12801 | 0.000 |
Why?
|
| Internship and Residency | 1 | 2007 | 5953 | 0.000 |
Why?
|